Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.90
+0.16 (2.79%)
At close: Oct 3, 2025, 4:00 PM EDT
5.97
+0.07 (1.19%)
Pre-market: Oct 6, 2025, 8:40 AM EDT
Solid Biosciences Employees
Solid Biosciences had 100 employees as of December 31, 2024. The number of employees increased by 12 or 13.64% compared to the previous year.
Employees
100
Change (1Y)
12
Growth (1Y)
13.64%
Revenue / Employee
n/a
Profits / Employee
-$1,540,840
Market Cap
459.43M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 100 | 12 | 13.64% |
Dec 31, 2023 | 88 | 1 | 1.15% |
Dec 31, 2022 | 87 | -17 | -16.35% |
Dec 31, 2021 | 104 | 34 | 48.57% |
Dec 31, 2020 | 70 | -51 | -42.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SLDB News
- 4 days ago - Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 days ago - Solid Biosciences to Present at Upcoming Scientific Meetings - GlobeNewsWire
- 11 days ago - Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting - GlobeNewsWire
- 13 days ago - Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101 - GlobeNewsWire
- 13 days ago - Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease - Business Wire
- 4 weeks ago - Solid Biosciences Inc. (SLDB) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 5 weeks ago - Solid Biosciences to Participate at Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire